Buy peptides South Africa

IGF1-LR3

(Insulin-like Growth Factor-1 – Long Release 3)

Go to | Back to Shop

 

Buy, Purchase, Peptides, research, South, Africa, ACE-031, AOD 9604, CJC-1295, CJC-1295 DAC, DSIP, Follistatin 344, GDF-8, GHRP-2, GHRP-6, HCG

IGF-1 is a peptide roughly the same structure and size as insulin, or about 70 amino acids long. It belongs to the peptide family of substances identified as growth factors. It is a highly anabolic hormone released in the liver as well as in peripheral tissues such as skeletal muscle. In the body, IGF-1 is released in response to the presence of Human Growth Hormone (HGH). After intense resistance training, the body experiences a surge in GH and IGF, and this is one way that new muscle is built. Although GH is considered to be highly anabolic, in actuality, IGF-1 is suspected to be responsible for the primary anabolic activities of GH.

 

IGF-1 builds new muscle tissue by promoting nitrogen retention and protein synthesis. This causes the growth of muscles through both hyperplasia (which is an increase in number of muscle cells) and mitogenesis (which is the actual growth of new muscle fibres). Thus IGF-1 not only makes muscle fibres bigger, it makes more of them as well!

 

IGF-1’s effects are not limited to building new muscle, however. It has a potent effect on lipid (fat) metabolism, and helps the body burn fat at a significantly elevated rate. In addition, IGF-1 is both a neuroprotector and neuropromotor, which improves mental functions such as reflexes, memory, and learning ability. IGF is also important for production of connective tissue and insuring proper bone density.

 

Although IGF-1 is very potent at building muscle and burning fat, the Lr3 IGF-1 version is roughly 2-3x as powerful.

 

Lr3IGF-1 (Long R3 Insulin-like Growth Factor-I or Long R3IGF-I) is an 83 amino acid analog of human IGF-I actually comprising the complete human IGF-1 sequence but with the substitution of an Arg for the Glu at position 3, as well as a 13 amino acid extension peptide at the N-terminus. This makes Long R3IGF-I significantly more potent (2-3x) than IGF-I in studies, because it has a lower affinity to be rendered inactive by IGF binding proteins, and consequently more potential activity in the body.

 

IGF1 LR3 also known as Long R3 IGF-1 or Insulin-Like Growth Factor-I LR3 is a Human Recombinant, single, non-glycosylated, polypeptide chain containing 83 amino acids and having a molecular mass of 9200 Daltons. IGF1 mediates many of the growth-promoting effects of growth hormone (GH; MIM 139250). Early studies showed that growth hormone did not directly stimulate the incorporation of sulfate into cartilage, but rather acted through a serum factor, termed ‘sulfation factor,’ which later became known as ‘somatomedin’.

 

IGF-1 LR3 is the primary protein involved in responses of cells to growth hormone (GH): that is, IGF-I is produced in response to GH and then induces cellular activities. One such example is muscle growth or hyperplasia. This compound also makes the human body more sensitive to insulin. It is the most potent growth factor found in the human body. IGF-1 causes muscle cell hyperplasia, which is an actual splitting and forming of new muscle cells.

 

The most effective form of IGF-1 is Long-R3 IGF-1. This formula has been chemically altered to avoid binding to proteins in the human body, and to increase the half life, approximately 20-30 hours.

 

Our Recommended Dosage

 

Inject 1ml bacteriostatic water into vial.

Draw out : 0.05iu (half of 0.1) per day

Bilaterally, Intramuscular

 

Go to | Back to Shop

Order and pay with credit or debit card here or use traditional order form here.
 
Share or Like this page :
    
 
Contact us - Email info@researchpeptides.co.za | Whatsapp : (060) 997 4604 | BBM Pin : PEPTIDES or D8DC1A4B
 
 
Please remember to read our disclaimer and consider it seriously. : View Disclaimer here,
Products sold for research purposes to registered establishments and persons.
Copyright Follistatin SA established 2006 - Copyright Research Peptides 2018 - Established 2013